Jeffrey Epstein on the Couch: Part III

Narcissism, antisocial, pedophilia… A lot of psychiatric terms have been used to explain Jeffrey Epstein. We’ll look at what fits.CME: Take the CME Post-Test for this EpisodePublished On: 03/23/2026Duration: 23 minutes, 38 secondsChris Aiken, MD, and Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Does money lead to happiness? What kind of stress causes depression? Why the FDA change their requirements for new drug approvals? And what happened between Jeffrey Epstein and Ghislaine Maxwell that launched an enterprise of abuse?CME: Take the CME Post-Test for this EpisodePublished On: 03/16/2026Duration: 16 minutes, 49 secondsChris Aiken, MD, and Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Narcissism, antisocial, pedophilia… We examine the diagnoses people invoke to explain Jeffrey Epstein and determine if any fit. CME: Take the CME Post-Test for this EpisodePublished On: 03/09/2026Duration: 15 minutes, 29 secondsChris Aiken, MD, and Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Pramipexole has moved up the in our algorithm for treatment resistant depression. Today, learn how to use this dopamine agonist.CME: Take the CME Post-Test for this EpisodePublished On: 03/02/2026Duration: 19 minutes, 24 secondsChris Aiken, MD, and Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

New research moves pramipexole up in the algorithm for treatment resistant depression.CME: Take the CME Post-Test for this EpisodePublished On: 02/23/2026Duration: 13 minutes, 41 secondsChris Aiken, MD, and Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We interview Steve Hayes, originator of Acceptance and Commitment Therapy, on the personal struggles that inspired the treatment.CME: Take the CME Post-Test for this EpisodePublished On: 02/16/2026Duration: 19 minutes, 01 secondsChris Aiken, MD, Kellie Newsome, PMHNP, and Steven Hayes, PhD, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

An interview with Steve Hayes, originator of Acceptance and Commitment Therapy (ACT), on how his struggle with panic disorder inspired his work. CME: Take the CME Post-Test for this EpisodePublished On: 02/09/2026Duration: 20 minutes, 32 secondsChris Aiken, MD, and Steven Hayes, PhD, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

A parent sits across from you and asks, "Why can't my child just take the same anxiety medicine that helps me?” Sounds reasonable, but the evidence tells a very different story.CME: Take the CME Post-Test for this EpisodePublished On: 02/02/2025Duration: 17 minutes, 53 secondsJoshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How a new FDA approved device for difficult-to-treat depression engages the brain through the sensory nerves in part II of our interview with Linda Carpenter.CME: Take the CME Post-Test for this EpisodePublished On: 01/26/2026Duration: 12 minutes, 33 secondsChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We interview Linda Carpenter, lead investigator on the new FDA approved device for difficult-to-treat depression.CME: Take the CME Post-Test for this EpisodePublished On: 01/19/2026Duration: 20 minutes, 49 secondsChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.